Sridhar Viswanathan

Sridhar Viswanathan joined Dren Bio as our EVP of Process Sciences and Manufacturing Operations in June 2021. Dr. Viswanathan most recently served as SVP of Process Sciences and Manufacturing Operations for CytomX Therapeutics. During his time at CytomX, he helped establish and lead their 30-person CMC team to advance CytomX’s pipeline based on a novel Probody technology platform developing conditionally active biologics. Prior to joining CytomX, Dr. Viswanathan co-founded a CMC consulting company, Fawkes Bio, and held executive level process development and manufacturing operations positions at Perseid Therapeutics and Maxygen. Dr. Viswanathan began his career at Rockefeller University after obtaining his PhD in Biochemistry from the University of Mississippi Medical Center.